This document discusses several sexually transmitted infections (STIs), including gonorrhea, chlamydia, syphilis, and HIV/AIDS. It describes the causative organisms, sites of infection, clinical features, complications, diagnosis, and treatment for each STI. STIs can cause local and distant infections and lead to serious complications like infertility, ectopic pregnancy, and pelvic inflammatory disease if left untreated. Proper diagnosis and treatment of STIs and prevention of transmission are important for individual and public health.
Other sites ofinfection
• Oropharynx
• anorectal region
• conjunctiva
8.
Clinical Features inadult
• 50 percent of patients with gonorrhea are
asymptomatic
• The clinical features are claasified as:
• Local.
• Distant or metastatic.
• PID
9.
Local
• Urinary symptomssuch as dysuria (25%)
• Excessive irritant vaginal discharge (50%)
• Acute unilateral pain and swelling over the labia due
to involvement of Bartholin’s gland
10.
• There maybe rectal discomfort due to associated
proctitis from genital contamination
• Others: Pharyngeal infection, intermenstrual
bleeding.
PREVENTIVE
• Adequate therapyfor gonococcal infection and meticulous follow up
are to be done till the patient is declared cured.
• To treat adequately the male sexual partner simultaneously.
• To avoid multiple sex partners.
• To use condom till both the sexual partners are free from disease.
18.
FOLLOW UP
• Culturesshould be made 7 days after the therapy.
• Repeat cultures are made at monthly intervals following menses
for three months.
• If the reports are persistently negative, the patient is
declared cured.
CLINICAL FEATURES
• 75%- non-specific and asymptomatic
• Dysuria,
• dyspareunia,
• postcoital bleeding
• intermenstrual bleeding
25.
COMPLICATIONS
• Urethritis andbartholinitis
• Chlamydial cervicitis spreads upwards to produce
endometritis and salpingitis.
• Chlamydial salpingitis infertility and ectopic
pregnancy
26.
DIAGNOSIS
• Chlamydial nucleicacid amplification testing
• Polymerase chain reaction (PCR) is a very sensitive and specific test
(95%)
• ELISA sensitivity less compared to NAAT
• Chlamydia can be demonstrated in tissue culture 100% specific
MODE OF SPREAD
•Syphilitic lesion of the genital tract is acquired by direct
contact with another person who has open primary or
secondary syphilitic lesion.
• Transmission occurs through the abraded skin or mucosal
surface.
30.
SITE OF INFECTION
•PRIMARY LESION Labia (may be single/
multiple)
• Other sites:-
• Fourchette,
• Anus
• Cervix
• nipples
31.
CLINICAL FEATURES
• Incubationperiod ranges between 9 and 90 days.
• PRIMARY A small papule is formed, which is quickly eroded to
form an ulcer.
• The margins are raised with smooth shiny floor.
• The ulcer is painless
• The inguinal glands are enlarged and painless.
• The primary chancre heals spontaneously in 1–8 weeks leaving
behind a scar.
32.
Secondary syphilis—
• Coarse,flat-topped, moist, necrotic lesions
• Systemic symptoms like fever, headache, and sore throat.
• Maculopapular skin rashes are seen on the palms and soles.
• Other features generalized lymphadenopathy, mucosal
ulcers, and alopecia.
33.
• LATENT SYPHILIS dormant phase after secondary syphilis
• TERTIARY SYPHILIS when not treated. Damages CNS, CVS,
MUSCULOSKELETAL SYSTEM.
• GUMMA Deep punched ulcer with rolled out margins.
• It is painless with a moist leather base
34.
DIAGNOSIS
• History ofexposure to an infected person.
• Identification of the organism—Treponema
pallidum, an anaerobe.
• VDRL +ve 6 weeks after initial infection
35.
SPECIFIC TEST
• Treponemapallidumhemagglutination (TPHA) test,
• Treponema pallidum enzyme immunoassay (EIA),
• fluorescent treponemal antibody absorption (FTA-abs)
test
• Treponema pallidum immobilization (TPI) test.
36.
FOLLOW UP:
• Serologicaltest is to be performed 1, 3, 6, and 12
months after treatment of early syphilis.
• In late symptomatic cases, surveillance is for life
• The serological test is to be done annually.
MODE OF TRANSMISSION
•Sexual intercourse
• Intravenous drug abusers.
• Transfusion of contaminated blood or blood products.
• Use of contaminated needles, needlestick injuries.
• Breastfeeding
40.
• Perinatal transmission—Thevertical transmission to the neonates
of the infected mothers is about 25–35%.
• The baby may be affected in utero (30%) through transplacental
transfer,
• During delivery (70–75%) by contaminated secretions and blood of
the birth canal.
42.
Gynecological symptomatology
• Infectionof the genital tract
• Vaginitis – recurrent candidiasis
• PID with other STIs
• Neoplasms of the genital tract are increased
• Increased incidence of wound infection
43.
• Menstrual abnormality:Menorrhagia, amenorrhea, or
abnormal uterine bleeding may be due to associated
weight loss, thrombocytopenia or opportunistic
infections or neoplasms.
44.
DIAGNOSIS
• CD 4cells
• Detection of IgG antibody to Gp 120 (envelope glycoprotein
component)
• Viral P-24 antigen Detected soon after the infection
• ELISA is extremely sensitive (99.5%) but less specific.
• Western blot or immunoblot—It is highly specific but complicated
and time consuming
• HIV RNA by PCR is the gold standard for diagnosis of HIV.
45.
TREATMENT
• Safer sexwith barrier methods
• Male circumcision reduces transmission by 50%.
• Use of blunt tipped needles to avoid needle stick injury during
surgery.
• HIV negative blood transfusion
• HIV negative frozen semen to use for artificial donor insemination.
• Termination of pregnancy in HIV positive women when requested.
46.
• Wide spreadvoluntary counseling and testing
• Mother needs to be counseled as regard the risks and
benefits of breastfeeding. She is helped to make an
informed choice.